All 12 Clinical Trial Participants Off External Insulin: New Data on Tegoprubart Continues to Impress
New data from a Breakthrough T1D–funded islet cell transplant trial shows all 12 participants are off external insulin using tegoprubart.
ADA 2026 Recap: Days 1 and 2
ADA’s 86th Scientific Sessions This event is one of the largest diabetes conferences in the world, bringing together over 11,000 attendees to share and learn about cutting-edge research and advancements toward cures. Each year, Breakthrough T1D-funded researchers highlight their work, demonstrating the progress we’re making toward achieving our mission. Leading experts will present over 100 […]
Breakthrough T1D Mourns the Loss of William V. Tamborlane, M.D.
Breakthrough T1D is deeply saddened at the passing of William V. Tamborlane, M.D. Dr. Tamborlane was a tireless champion for the type 1 diabetes (T1D) community, a pioneering clinical scientist, dedicated physician, and longtime Breakthrough T1D partner, grantee, reviewer, advisor, and friend. “Bill Tamborlane was a giant in our field, and he will be terribly […]
Afrezza Rapid-Acting Inhaled Insulin Approved for Children and Adolescents with T1D
Afrezza, a rapid-acting, inhaled mealtime insulin, has been approved by the FDA for use in children and adolescents ages 6+ with T1D.
First Automated Insulin Delivery System Approved for Pregnancy with Type 1 Diabetes
Tandem’s Control-IQ+ is the first-ever automated insulin delivery system cleared in the U.S. for pregnancy with type 1 diabetes.
It’s that time of year: ADA’s 86th Scientific Sessions are coming up
It’s that time of year again: the American Diabetes Association’s (ADA) 86th Scientific Sessions is taking place from June 5-8, 2026. Scientists, researchers, healthcare professionals, and industry leaders will travel to New Orleans, LA for the biggest annual diabetes conference in the world. Breakthrough T1D will be there to join the discussion about the latest-and-greatest […]
International Experts Advance Clinical Adoption of Islet Cell Therapies at Breakthrough T1D HQ
Islet cell therapies for type 1 diabetes (T1D) replace destroyed insulin-producing beta cells with functional cells that allow the body to make insulin again. To ensure there are enough islet cells for everyone with T1D who wants them, Breakthrough T1D is prioritizing manufactured cell therapies, which can be made in large quantities in a laboratory, […]
An Interview with Vertex
It’s an exciting time for type 1 diabetes (T1D) research. Nearly every day, we’re seeing incredible progress across each area of Breakthrough T1D’s research portfolio to cure, prevent, and treat T1D and its complications. One area in particular is making headlines: Cell therapies. In T1D, the immune system destroys the beta cells in the pancreas, which produce insulin. Cell therapies aim to replace […]
Balancing Mental Health and Type 1 Diabetes
Taking care of your mental health with type 1 diabetes is just as important as managing your blood sugar and taking your insulin.
C-peptide: Everything You Need to Know
It was identified in the late 1960s. Since then, studies have shown that it is a biomarker for beta cell function. In other words, it’s a measure of beta cell health and insulin production. If it’s low (or you have none), it indicates that your pancreas is producing little or no insulin. There was even […]
